Boston Scientific Corporation(BSX)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
BSX | 60.93 B | 17.16x | 7.50% | 17.50% | $2.45 | 15.34% | 0.50x | 0.00% | $105.65 | $42.20 |
ABT | 170.43 B | 32.51x | 13.00% | 11.65% | $3.03 | 10.58% | 0.63x | 2.56% | $132.31 | $81.39 |
ISRG | 148.83 B | 48.36x | 18.50% | 28.45% | $8.59 | 17.42% | - | 0.00% | $603.88 | $328.57 |
SYK | 106.24 B | 29.00x | 9.40% | 14.43% | $9.55 | 16.51% | 0.64x | 1.27% | $388.25 | $266.16 |
EW | 48.56 B | 50.75x | 13.60% | 15.43% | $1.66 | 9.18% | 6.57x | 0.00% | $96.29 | $72.30 |
Peer Valuation & Performance Analysis
Peer group analysis for Boston Scientific Corporation (BSX) compared to its primary competitors (including ABT, ISRG, SYK) reveals distinct metrics. BSX trades at a valuation discount relative to its competitors, with a P/E ratio of 17.2x versus the peer average of 40.2x (representing a 57% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, BSX's revenue growth of 7.5% lags behind the peer average of 13.6%, indicating potential market share losses or slower industry adoption. Additionally, its net margin of 17.5% is comparable to the peer average of 17.5%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• BSX ranks #1 in P/E ratio, #5 in revenue growth, and #2 in profit margins
• Average ranking: #3 - 📊 Solid financials relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-08 | $41.50 | $42.27 | $41.39 | $42.04 | 22,873,400 | +1.11% |
| 2026-10-07 | $42.19 | $42.52 | $41.50 | $41.58 | 15,892,400 | -1.45% |
| 2026-10-06 | $42.47 | $42.75 | $42.00 | $42.19 | 12,545,600 | -0.50% |
| 2026-10-05 | $42.53 | $43.30 | $42.29 | $42.40 | 13,737,400 | -0.47% |
| 2026-10-02 | $43.32 | $43.44 | $41.94 | $42.60 | 18,313,900 | -1.46% |
| 2026-10-01 | $43.51 | $43.96 | $42.95 | $43.23 | 17,931,800 | -0.96% |
| 2026-09-30 | $43.74 | $43.97 | $43.30 | $43.65 | 17,967,400 | -0.52% |
| 2026-09-29 | $44.15 | $44.30 | $43.22 | $43.88 | 14,603,500 | -0.52% |
| 2026-09-28 | $43.91 | $44.15 | $43.17 | $44.11 | 21,779,600 | +0.43% |
| 2026-09-25 | $44.68 | $44.84 | $43.33 | $43.92 | 15,205,400 | -1.70% |
| 2026-09-24 | $44.65 | $45.16 | $44.46 | $44.68 | 17,296,200 | +0.13% |
| 2026-09-23 | $45.00 | $45.74 | $43.99 | $44.62 | 18,564,400 | -0.67% |
| 2026-09-22 | $44.70 | $45.08 | $44.04 | $44.92 | 21,075,000 | +2.74% |
| 2026-09-21 | $42.98 | $43.81 | $42.72 | $43.72 | 24,995,400 | +0.88% |
| 2026-09-18 | $43.08 | $43.90 | $43.05 | $43.34 | 29,277,700 | -0.48% |
Explore More Analysis for BSX
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.